… Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer:
… Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy. J …

… The success of chemotherapeutic measures in the treatment of small cell lung cancer has
tended … In one of the latter trials (76) the majority of patients had received prior chemotherapy …

… Trials should have aimed to include patients who had undergone a potentially curative
resection and not received previous chemotherapy. For the first meta‐analysis, trials should have …

… cell lines reflects clinical drug resistance still remains unanswered. In this study, a pair of
lung cancer cell lines … from lung cancer have increased rapidly in recent decades [1]. Non-small-…

… - or fourth-line chemotherapy after two prior chemotherapy regimens that included platinum
… Prior regiments had failed due to discase progression within 90 days of chemotherapy, or …

… Effectiveness of prior chemotherapy and time from last administration was found to …
responders to prior chemotherapy responded to VM26, while 0% of the nonresponders to prior che- …

… after prior adjuvant chemotherapy, … -cell lung cancer who undergo adjuvant systemic
therapy: median age 63 years, 40%–50% adenocarcinoma, 30%–40% squamous cell carcinoma, …

… Patients who had received prior chemotherapy were ineligible for the study. The criteria for
eligibility included confirmed disease, measurable or nonmeasurable; an age of at least 18 …

… non-small cell lung cancer (NSCLC)… chemotherapy in advanced disease. Evaluation of the
role of maintenance therapy following four to six cycles of first-line combination chemotherapy …

… biopsy to evaluate mutations in lung cancer specimens, especially in the … lung cancer.
Rebiopsy, when performed in patients who have NSCLC that is resistant to prior chemotherapy or …